With the lifting of COVID-19 non-pharmaceutical interventions, the resurgence of common
viral respiratory infections was recorded in several countries worldwide. It facilitates viral co …

Emerging Oseltamivir-resistant influenza strains pose a critical public health threat due to
antigenic shifts and drifts. We report an innovative strategy for controlling influenza A …

The emergence of anti-influenza drug-resistant strains poses a challenge for influenza
therapy due to mutations in the virus's surface protein. Recently, there has been increasing …

The virus behind the current pandemic, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) is responsible for the etiology of novel coronavirus disease (COVID-19) and …

H7N9 influenza viruses emerged in 2013 and have caused severe disease and deaths in
humans in China. Some H7N9 viruses circulating in chickens have mutated to highly …

With the widespread vaccinations against coronavirus disease 2019 (COVID-19), we are
witnessing gradually waning neutralizing antibodies and increasing cases of breakthrough …

The positive-sense single-stranded (ss) RNA viruses of the Betacoronavirus (beta-CoV)
genus can spillover from mammals to humans and are an ongoing threat to global health …

The antiviral effect of a catalytic RNA-hydrolyzing antibody, 3D8 scFv, for intranasal
administration against avian influenza virus (H1N1) was described. The recombinant 3D8 …

The Omicron variant is sweeping the world, which displays striking immune escape potential
through mutations at key antigenic sites on the spike protein, making broad-spectrum SARS …

Abstract Current SARS-CoV-2 Omicron subvariants impose a heavy burden on global health
systems by evading immunity from most developed neutralizing antibodies and vaccines …